PET and PET/CT in Endocrine Tumours

Overview

Journal Eur J Radiol

Specialty Radiology

Date 2010 Jan 22

PMID 20089377

Citations 6

Authors

Robert Dudczak

Tatjana Traub-Weidinger

Affiliations

Soon will be listed here.

Abstract

Functional information provided by PET tracers together with the superior image quality and the better data quantification by PET technology had a changing effect on the significance of nuclear medicine in medical issues. Recently introduced hybrid PET/CT systems together with the introduction of novel PET radiopharmaceuticals have contributed to the fact that nuclear medicine has become a growing diagnostic impact on endocrinology. In this review imaging strategies, different radiopharmaceuticals including the basic mechanism of their cell uptake, and the diagnostic value of PET and PET/CT in endocrine tumours except differentiated thyroid carcinomas will be discussed.

Citing Articles

Endocrinology application of molecular imaging: current role of PET/CT.

Calderoni L, Giovanella L, Fanti S J Endocrinol Invest. 2024; 47(10):2383-2396.

PMID: 38837101 PMC: 11393017. DOI: 10.1007/s40618-024-02400-8.

Evolving management of insulinoma: Experience at a tertiary care centre.

Jyotsna V, Pal S, Kandasamy D, Gamanagatti S, Garg P, Raizada N Indian J Med Res. 2017; 144(5):771.

PMID: 28361831 PMC: 5393089. DOI: 10.4103/ijmr.IJMR_1477_14.

Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports.

Giannetta E, Gianfrilli D, Pozza C, Lauretta R, Graziadio C, Sbardella E Medicine (Baltimore). 2016; 95(3):e2419.

PMID: 26817871 PMC: 4998245. DOI: 10.1097/MD.0000000000002419.

Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.

Gaujoux S, Sauvanet A, Belghiti J Target Oncol. 2012; 7(3):153-9.

PMID: 22923166 DOI: 10.1007/s11523-012-0230-0.

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.

Jensen R, Cadiot G, Brandi M, de Herder W, Kaltsas G, Komminoth P Neuroendocrinology. 2012; 95(2):98-119.

PMID: 22261919 PMC: 3701449. DOI: 10.1159/000335591.